As part of the restructuring, Silence has lowered the headcount at its Berlin research facility to 27 from 32.
Silence said that the offering, if completed, would extend its cash runway from the third quarter of this year until mid-2012.
Plasticell has formed a spinout called Progenitor Labs, which will focus on regenerative drug discovery.
The Australian gel and protein detection firm sold its US subsidiary and its flagship technology in recent months and is now targeting acquisitions moving ahead.
Collins' "bold" plan to break up NCRR to catalyze translational science is drawing fire over its process and its plans for NCRR, as well as notes of caution from seasoned senators.
It was not immediately clear what impact the move would have on the programs overseen by the unit.
An article about an acquisition topped the list of the most-read stories for the year on GenomeWeb Daily News, while restructurings, lawsuits, and one firm's IPO plans made it into the top 10.
According to the company, it is responding to "mounting cost pressures in healthcare" and to "increasing hurdles for the approval and pricing of new medicines."
The firm's Pharmaceutical Divisions will be primarily affected by the job cuts and transfers. The program is expected to result in annual cost savings of CHF2.4 billion ($2.4 billion) for Roche.
The firm's lab services revenues were hurt by lower sample volume, but were partially offset by a higher average price per sample. Celera also announced a restructuring program intended to cut costs by $10 million next year.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.